CytomX Therapeutics, Inc. (CTMX)

3.81 +0.12 (+3.25%) USD  |  NASDAQ  |  May 27, 16:00
3.84 +0.03 (+0.79%) After-Hours: 20:00
More

CytomX Therapeutics Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for CTMX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. Upgrade
Rigel Pharmaceuticals, Inc. Upgrade
Ovid Therapeutics, Inc. Upgrade
Gossamer Bio, Inc. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade